The CEA in serum and lymph node metastasis would promote the infiltration and metastasis of CRC, leading to higher risk of synchronous BM in CRC patients [17, 18]. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.